Stream Biomedical
Stream Biomedical: Innovating neuroprotective therapies for stroke, brain injury, and spinal cord treatment.
Stream Biomedical: Innovating neuroprotective therapies for stroke, brain injury, and spinal cord treatment.
Stream Biomedical is a product development company dedicated to innovating neuroprotective and neuroreparative therapies. The company focuses on addressing unmet therapeutic needs for individuals suffering from neurological trauma or degeneration, including acute stroke, traumatic brain injury, spinal cord injury, Alzheimer's, vascular dementia, and Parkinson's. Stream Biomedical holds licenses for intellectual property related to the therapeutic use of its biologics, aiming to preserve brain function and improve patient outcomes.
Notable affiliated individuals and investors have not been publicly disclosed. However, Stream Biomedical has achieved significant milestones in developing its proprietary biologic therapies. The company's impact lies in its potential to revolutionize treatment options for severe neurological conditions, offering hope for improved recovery and quality of life for patients. Through its innovative approach, Stream Biomedical aims to make substantial contributions to the field of neurotherapeutics.
Companies similar to Stream Biomedical include Neuraly, Premier Biomedical, Regennova and Acorda Therapeutics.
Stream Biomedical was founded in 2016.
Stream Biomedical's headquarters is located in Houston, TX, US.
Stream Biomedical's most recent funding round was for $21.5M (USD) in January 2022.
As of Jan 7, 2022, Stream Biomedical has disclosed funding of $21.5M (USD). Undisclosed round amounts are excluded.
Stream Biomedical has 8 employees as of Feb 5, 2024.
Acorda Therapeutics
acorda.com